| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.095 | 0.09 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |